Nasdaq · Financials
CME GROUP INC. (CME)
As-reported financials and recent SEC filings for CME GROUP INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$6.52B
Net income
$4.07B
Net margin
62.5%
Diluted EPS
$11.16
ROE
14.2%
P/E (TTM)
23.0×
Market cap
$97.39B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B |
| Gross profit | — | — | — | — | — |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B |
| Diluted EPS | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
DEFA14A2026-05-19
View on EDGAR →42026-05-19
View on EDGAR →8-K2026-05-19
View on EDGAR →1442026-05-18
View on EDGAR →42026-05-18
View on EDGAR →1442026-05-15
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →8-K2026-04-27
View on EDGAR →Go deeper on CME
Search CME GROUP INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.